O60271 (JIP4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 106.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: C-Jun-amino-terminal kinase-interacting protein 4 Short name=JIP-4 Short name=JNK-interacting protein 4 Alternative name(s): Cancer/testis antigen 89 Short name=CT89 Human lung cancer oncogene 6 protein Short name=HLC-6 JNK-associated leucine-zipper protein Short name=JLP Mitogen-activated protein kinase 8-interacting protein 4 Proliferation-inducing protein 6 Protein highly expressed in testis Short name=PHET Sperm surface protein Sperm-associated antigen 9 Sperm-specific protein Sunday driver 1 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1321 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Isoform 5 may play a role in spermatozoa-egg-interaction. Ref.11 Ref.12 |
| Subunit structure | Homooligomer. Interacts with MAX, MAPK8, MAPK9, MAPK10, MAPK14, MAP3K3, MYC, KNS2 and MAP2K4. Interaction with KNS2 is important in the formation of ternary complex with MAPK8. Interacts with NFKB1. Ref.11 Ref.12 |
| Subcellular location | Cytoplasm. Cytoplasm › perinuclear region. Note: Perinuclear distribution in response to stress signals such as UV radiation. Ref.9 Ref.12 Isoform 5: Cytoplasmic vesicle › secretory vesicle › acrosome. Note: Associated with the plasma membrane of the acrosomal compartment and also localizes in the acrosome matrix. Ref.9 Ref.12 |
| Tissue specificity | Isoform 5 is expressed only in testis on the round spermatids of stage I, II and II. Isoform 5 is absent in spermatogonia and spermatocyte. Isoform 3 is expressed in testis. Isoform 4 is expressed in testis and in acute myeloid leukemia (AML) patients. Ref.2 Ref.8 Ref.9 |
| Induction | Isoform 3 is increased in systemic sclerosis fibroblasts. Ref.9 |
| Post-translational modification | Phosphorylated by MAPK8 and MAPK14 By similarity. |
| Sequence similarities | Belongs to the JIP scaffold family. |
| Sequence caution | The sequence AAH07524.1 differs from that shown. Reason: Probable cloning artifact. The sequence AAH59946.1 differs from that shown. Reason: Probable cloning artifact. The sequence AAI06049.1 differs from that shown. Reason: Contaminating sequence. Sequence of unknown origin in the C-terminal part. The sequence AAO66462.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAA25442.3 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence BAB14812.1 differs from that shown. Reason: Unlikely isoform. Aberrant splicing. The sequence CAA62987.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Alternative products
| This entry describes 6 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O60271-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O60271-2) The sequence of this isoform differs from the canonical sequence as follows: 248-261: Missing. 555-555: F → FVPTR | ||||||
| Isoform 3 (identifier: O60271-3) The sequence of this isoform differs from the canonical sequence as follows: 938-945: SNDSDAYK → RYNNGSST 946-1321: Missing. | ||||||
| Note: Due to intron retention. | ||||||
| Isoform 4 (identifier: O60271-4) The sequence of this isoform differs from the canonical sequence as follows: 248-261: Missing. | ||||||
| Isoform 5 (identifier: O60271-5) The sequence of this isoform differs from the canonical sequence as follows: 248-261: Missing. 938-945: SNDSDAYK → RYNNGSST 946-1321: Missing. | ||||||
| Isoform 6 (identifier: O60271-9) The sequence of this isoform differs from the canonical sequence as follows: 1-196: MELEDGVVYQ...QLESTAHSRI → MSPGCMLLFV...ALTQNLPRIL 248-261: Missing. 1175-1175: T → TVILHQGRLLGLRA | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1321 | 1321 | C-Jun-amino-terminal kinase-interacting protein 4 | PRO_0000234076 | |||||||
Regions | |||||||||||
| Coiled coil | 66 – 166 | 101 | Potential | ||||||||
| Coiled coil | 408 – 534 | 127 | Potential | ||||||||
| Coiled coil | 724 – 758 | 35 | Potential | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 109 | 1 | Phosphoserine Ref.14 | ||||||||
| Modified residue | 183 | 1 | Phosphoserine Ref.16 Ref.18 Ref.20 | ||||||||
| Modified residue | 185 | 1 | Phosphoserine Ref.16 Ref.20 | ||||||||
| Modified residue | 194 | 1 | Phosphoserine Ref.18 | ||||||||
| Modified residue | 203 | 1 | Phosphoserine Ref.13 Ref.17 Ref.18 | ||||||||
| Modified residue | 217 | 1 | Phosphothreonine Ref.13 Ref.16 Ref.17 Ref.18 | ||||||||
| Modified residue | 244 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 251 | 1 | Phosphoserine Ref.18 | ||||||||
| Modified residue | 265 | 1 | Phosphoserine Ref.14 Ref.18 | ||||||||
| Modified residue | 268 | 1 | Phosphoserine Ref.18 | ||||||||
| Modified residue | 272 | 1 | Phosphoserine Ref.14 Ref.18 | ||||||||
| Modified residue | 292 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 311 | 1 | Phosphoserine Ref.16 | ||||||||
| Modified residue | 329 | 1 | Phosphoserine Ref.16 Ref.18 Ref.20 | ||||||||
| Modified residue | 332 | 1 | Phosphoserine Ref.16 Ref.18 Ref.20 | ||||||||
| Modified residue | 347 | 1 | Phosphoserine Ref.18 | ||||||||
| Modified residue | 348 | 1 | Phosphothreonine Ref.18 | ||||||||
| Modified residue | 365 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 418 | 1 | Phosphothreonine Ref.14 Ref.16 Ref.18 | ||||||||
| Modified residue | 586 | 1 | Phosphothreonine Ref.16 | ||||||||
| Modified residue | 730 | 1 | Phosphoserine Ref.18 | ||||||||
| Modified residue | 733 | 1 | Phosphoserine Ref.16 Ref.17 Ref.18 | ||||||||
Natural variations | |||||||||||
| Alternative sequence | 1 – 196 | 196 | MELED…AHSRI → MSPGCMLLFVFGFVGGAVVI NSAILVSLSVLLLVHFSIST GVPALTQNLPRIL in isoform 6. | VSP_042253 | |||||||
| Alternative sequence | 248 – 261 | 14 | Missing in isoform 2, isoform 4, isoform 5 and isoform 6. | VSP_018214 | |||||||
| Alternative sequence | 555 | 1 | F → FVPTR in isoform 2. | VSP_018220 | |||||||
| Alternative sequence | 938 – 945 | 8 | SNDSDAYK → RYNNGSST in isoform 3 and isoform 5. | VSP_018221 | |||||||
| Alternative sequence | 946 – 1321 | 376 | Missing in isoform 3 and isoform 5. | VSP_018222 | |||||||
| Alternative sequence | 1175 | 1 | T → TVILHQGRLLGLRA in isoform 6. | VSP_042254 | |||||||
| Natural variant | 1320 | 1 | N → S. Corresponds to variant rs9896965 [ dbSNP | Ensembl ]. | VAR_059364 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 451 | 1 | E → G in AAO66462. Ref.9 | ||||||||
| Sequence conflict | 680 | 1 | E → K in CAA62987. Ref.8 | ||||||||
| Sequence conflict | 680 | 1 | E → K in AAO66462. Ref.9 | ||||||||
| Isoform 6: | |||||||||||
| Sequence conflict | 9 | 1 | F → S in BAG58134. Ref.5 | ||||||||
Secondary structure | |||||||||||
Helix Strand Turn | |||||||||||
| Helix | 406 – 465 | 60 | |||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "JLP: a scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors." Lee C.M., Onesime D., Reddy C.D., Dhanasekaran N., Reddy E.P. Proc. Natl. Acad. Sci. U.S.A. 99:14189-14194(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Tissue: Liver. |
| [2] | "Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia." Guinn B.-A., Bland E.A., Lodi U., Liggins A.P., Tobal K., Petters S., Wells J.W., Banham A.H., Mufti G.J. Biochem. Biophys. Res. Commun. 335:1293-1304(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), TISSUE SPECIFICITY. |
| [3] | "Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro." Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 5:31-39(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [4] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SEQUENCE REVISION. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 6). Tissue: Brain and Testis. |
| [6] | "DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage." Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A., Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J., Chang J.L. Nusbaum C.Nature 440:1045-1049(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 6), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-478 (ISOFORMS 2/4/5). Tissue: Eye and Kidney. |
| [8] | "Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif." Shankar S., Mohapatra B., Suri A. Biochem. Biophys. Res. Commun. 243:561-565(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 130-1321 (ISOFORM 5), TISSUE SPECIFICITY. Tissue: Testis. |
| [9] | "A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies." Yasuoka H., Ihn H., Medsger T.A. Jr., Hirakata M., Kawakami Y., Ikeda Y., Kuwana M. J. Immunol. 171:6883-6890(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 162-1321 (ISOFORM 3), TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INDUCTION. Tissue: Testis. |
| [10] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [11] | "A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway." Bouwmeester T., Bauch A., Ruffner H., Angrand P.-O., Bergamini G., Croughton K., Cruciat C., Eberhard D., Gagneur J., Ghidelli S., Hopf C., Huhse B., Mangano R., Michon A.-M., Schirle M., Schlegl J., Schwab M., Stein M.A. Superti-Furga G.Nat. Cell Biol. 6:97-105(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH NFKB1. |
| [12] | "Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein." Jagadish N., Rana R., Selvi R., Mishra D., Garg M., Yadav S., Herr J.C., Okumura K., Hasegawa A., Koyama K., Suri A. Biochem. J. 389:73-82(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH MAPK9; MAPK10 AND MAPK8, SUBCELLULAR LOCATION, MASS SPECTROMETRY. |
| [13] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND THR-217, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-265; SER-272 AND THR-418, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [15] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [16] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; SER-185; THR-217; SER-311; SER-329; SER-332; THR-418; THR-586 AND SER-733, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203; THR-217 AND SER-733, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [18] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; SER-194; SER-203; THR-217; SER-251; SER-265; SER-268; SER-272; SER-329; SER-332; SER-347; THR-348; THR-418; SER-730 AND SER-733, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [20] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; SER-185; SER-329 AND SER-332, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF327452 mRNA. Translation: AAN61565.1. AY850123 mRNA. Translation: AAX47276.1. AB011088 mRNA. Translation: BAA25442.3. Different initiation. AK024068 mRNA. Translation: BAB14812.1. Sequence problems. AK295098 mRNA. Translation: BAG58134.1. AK302789 mRNA. Translation: BAG63993.1. AC005920 Genomic DNA. No translation available. AC005839 Genomic DNA. No translation available. BC007524 mRNA. Translation: AAH07524.1. Sequence problems. BC059946 mRNA. Translation: AAH59946.1. Sequence problems. BC106048 mRNA. Translation: AAI06049.1. Sequence problems. BC146755 mRNA. Translation: AAI46756.1. BC153878 mRNA. Translation: AAI53879.1. X91879 mRNA. Translation: CAA62987.1. Different initiation. AY219897 mRNA. Translation: AAO66462.1. Different initiation. AY219898 mRNA. Translation: AAO66463.1. | ||||||||||||
| IPI | IPI00303397. IPI00384432. IPI00479676. IPI00744288. IPI00744648. IPI00748244. IPI00748833. IPI00879552. IPI01011459. | ||||||||||||
| PIR | JC5958. | ||||||||||||
| RefSeq | NP_001123999.1. NM_001130527.2. NP_001124000.1. NM_001130528.2. NP_001238900.1. NM_001251971.1. NP_003962.3. NM_003971.5. | ||||||||||||
| UniGene | Hs.463439. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | O60271. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | O60271. 5 interactions. | ||||||||||||
| MINT | MINT-1136008. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | O60271. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | O60271. | ||||||||||||
| PRIDE | O60271. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 9043. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000262013; ENSP00000262013; ENSG00000008294. ENST00000357122; ENSP00000349636; ENSG00000008294. ENST00000505279; ENSP00000426900; ENSG00000008294. ENST00000510283; ENSP00000423165; ENSG00000008294. | ||||||||||||
| GeneID | 9043. | ||||||||||||
| KEGG | hsa:9043. | ||||||||||||
| UCSC | uc002itb.3. human. uc002itc.3. human. uc002itd.3. human. uc002ite.3. human. uc002itf.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 9043. | ||||||||||||
| GeneCards | GC17M049039. | ||||||||||||
| HGNC | HGNC:14524. SPAG9. | ||||||||||||
| HPA | HPA040446. | ||||||||||||
| MIM | 605430. gene. | ||||||||||||
| neXtProt | NX_O60271. | ||||||||||||
| PharmGKB | PA37890. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG270333. | ||||||||||||
| HOGENOM | HOG000290716. | ||||||||||||
| HOVERGEN | HBG024110. | ||||||||||||
| InParanoid | O60271. | ||||||||||||
| OMA | KKLWCAV. | ||||||||||||
| OrthoDB | EOG4QJRMF. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_111045. Developmental Biology. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | O60271. | ||||||||||||
| Bgee | O60271. | ||||||||||||
| Genevestigator | O60271. | ||||||||||||
| GermOnline | ENSG00000008294. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.130.10.10. 1 hit. | ||||||||||||
| InterPro | IPR019143. JNK/Rab-associated_protein-1_N. IPR015943. WD40/YVTN_repeat-like_dom. IPR017986. WD40_repeat_dom. [Graphical view] | ||||||||||||
| Pfam | PF09744. Jnk-SapK_ap_N. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF50978. WD40_like. 1 hit. | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | SPAG9. human. | ||||||||||||
| EvolutionaryTrace | O60271. | ||||||||||||
| GenomeRNAi | 9043. | ||||||||||||
| NextBio | 33871. | ||||||||||||
| PMAP-CutDB | O60271. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | JIP4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O60271 Secondary accession number(s): A6H8U5 Q9H811 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
